JPS61249989A - 7-amino-3-propenylcephalosporanic acid and ester - Google Patents

7-amino-3-propenylcephalosporanic acid and ester

Info

Publication number
JPS61249989A
JPS61249989A JP61091419A JP9141986A JPS61249989A JP S61249989 A JPS61249989 A JP S61249989A JP 61091419 A JP61091419 A JP 61091419A JP 9141986 A JP9141986 A JP 9141986A JP S61249989 A JPS61249989 A JP S61249989A
Authority
JP
Japan
Prior art keywords
group
formula
hydrogen
amino
formulas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP61091419A
Other languages
Japanese (ja)
Other versions
JPH0327554B2 (en
Inventor
星 英秋
奥村 潤
阿部 芳男
隆之 内藤
油木 慎平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of JPS61249989A publication Critical patent/JPS61249989A/en
Publication of JPH0327554B2 publication Critical patent/JPH0327554B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/187-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 〈産業上の利用分野〉 本発明は新規なセファロスポリン中間体、その酸付加塩
及びその金属塩に関する◇これらの化合物は経口で活性
なセファロスポリン製造用の中間体として有用である。
[Detailed Description of the Invention] <Industrial Application Field> The present invention relates to novel cephalosporin intermediates, acid addition salts thereof and metal salts thereof ◇These compounds are used as intermediates for the production of orally active cephalosporins. It is useful for the body.

〈従来の技術〉 1974年1月3日発行の(1973年10月3.0日
、及び1976年11A30日付与された米国特許第3
,769゜277号及び第3,994.884号に対応
する)英国特許第1.342,241号明Jlli書は
化合物■:oon を開示しているが、その製造法中には中間体として7β
−アミノ−3−〔(Z) −1−プロペン−1−イル〕
−3−セフェム−4−カルボン酸の記載は無い。
<Prior Art> U.S. Pat.
, 769°277 and 3,994.884) discloses the compound ■:ooon, but the process for its preparation involves the use of 7β
-amino-3-[(Z)-1-propen-1-yl]
There is no description of -3-cephem-4-carboxylic acid.

1983年10月11日付の米国特許第4,409,2
14号は製造法38及び39中で、ジフェニルメチル7
−ペンジリデンアミノー3−トリフェニルホスホニオメ
チルセフ−3−エム−4−カルボキシレートでのウィツ
テイヒ反応経由の化合物■: の製造法を開示している、然し7β−アミノ−3〔(Z
) −1−プロペン−1−イル〕−3−セフェム−4−
カルボン酸、又ハその他の3−(1−プロペン−1−イ
ル)セファロスポリン化合物の記載は無い。
U.S. Patent No. 4,409,2, dated October 11, 1983.
No. 14 uses diphenylmethyl 7 in production methods 38 and 39.
- discloses a method for the preparation of compound ■: via Witzteig reaction with penzylideneamino-3-triphenylphosphoniomethylcef-3-em-4-carboxylate, but 7β-amino-3 [(Z
) -1-propen-1-yl]-3-cephem-4-
There is no description of carboxylic acids or other 3-(1-propen-1-yl)cephalosporin compounds.

1978年4月29日付の米国特許第4,110,53
4号は特にウィツテイヒ反応による■及び■の様々化合
物の製造法に関するものである0特に第8.9及び49
1m!l(実施例21)参照0 エッチ・オー・ハウス(H,O,House )等;ジ
ャーナル・オブ・オーガニック・ケミストリー(Jou
r、 Org、 Chem、)第29巻、第3327〜
3333負(1964年)は、アルデヒドを用いるウィ
ツテイヒ反応で生成するcim−及びtrans−オレ
フィンの比率について溶媒及びリチウム塩を含めた添加
物の影蕃を検討した0 〈発明の構成〉 本発明は式Iを有するセファロスポリン中間体、合成的
に有用なその酸付加塩及び金属塩、及びこれらの製造方
法に関する。
U.S. Patent No. 4,110,53 dated April 29, 1978
No. 4 is particularly concerned with the production of various compounds of ■ and ■ by the Witteigh reaction.
1m! l (Example 21) Reference 0 H, O, House et al.; Journal of Organic Chemistry (Jou
r, Org, Chem,) Volume 29, No. 3327~
3333 Negative (1964) investigated the influence of solvents and additives including lithium salts on the ratio of cim- and trans-olefins produced in the Witzteich reaction using aldehydes. The present invention relates to cephalosporin intermediates having I, synthetically useful acid addition salts and metal salts thereof, and methods for their production.

OOR 式Iの化合物では3−プロペニル基の立体配置は2−又
はaim−である。Rは水素又は通常のカルボン酸保護
基である01通常のカルボン酸保護基”の表現はセファ
ロスポリン化合物の合成で通常アミノ又はカルボキシル
基に就いて使用される種類の保護基を指す。適切なカル
ボン酸保護基にはアラルキル基例えばベンジル、p−メ
トキシベンジル、0−ニトロベンジル、p−ニトロベン
ジル及ヒシフェニルメチル(ベンズヒドリル);アルキ
ル基例えばt−ブチル;ハロアルキル基例えばλ2,2
−)リククロエチル;アルケニル基例えばアリル、2−
クロロアリル;アルコキシメチル基例えばメトキシメチ
ル、2−(トリメチルシリル)エチル、トリメチルシリ
ル、tert−ブチルジメチルシリル、tart−ブチ
ルジフェニルシリル、及び文献中、例えば英国特許第1
,399,086号明細書に記載されたその他のカルボ
ン酸保護基が包含される0%に好ましいカルボン酸保護
基は酸を用いる処理によって容易に除去されるベンズヒ
ドリル基又はt−ブチル基である。前述の物質の酸付加
塩及びRが水素である物質の金属塩も本発明の一部であ
る。
OOR In compounds of formula I, the configuration of the 3-propenyl group is 2- or aim-. R is hydrogen or a conventional carboxylic acid protecting group. The expression "common carboxylic acid protecting group" refers to the type of protecting group commonly used for amino or carboxyl groups in the synthesis of cephalosporin compounds. Carboxylic acid protecting groups include aralkyl groups such as benzyl, p-methoxybenzyl, 0-nitrobenzyl, p-nitrobenzyl and hiscyphenylmethyl (benzhydryl); alkyl groups such as t-butyl; haloalkyl groups such as λ2,2
-) Likuloethyl; alkenyl group e.g. allyl, 2-
Chloroallyl; alkoxymethyl groups such as methoxymethyl, 2-(trimethylsilyl)ethyl, trimethylsilyl, tert-butyldimethylsilyl, tart-butyldiphenylsilyl, and in the literature, e.g. British Patent No. 1
, 399,086, 0% preferred carboxylic acid protecting groups are benzhydryl or t-butyl groups, which are easily removed by treatment with acid. Acid addition salts of the aforementioned substances and metal salts of substances in which R is hydrogen are also part of the invention.

3−プロペニル基の2−1又はcia−配置が本発明の
化合物の主題である。これは出願人の米国特許第4,5
20,022号の対象であるセファロスポリン最終生成
物の有利なダラム陰性菌に対する抗菌性を決定している
特徴である0合成上有用な酸付加塩には、鉱酸例えば塩
酸、硫酸及び燐酸との塩、有機スルホン酸例えばp−ト
ルエンスルホン酸及びセファロスポリンの技術分野で公
知であシ、使用されているその他の酸との塩である、式
■の塩が包含される。
The 2-1 or cia-configuration of the 3-propenyl group is the subject of the compounds of the invention. This is applicant's U.S. Patent Nos. 4 and 5.
Synthetically useful acid addition salts include mineral acids such as hydrochloric acid, sulfuric acid and phosphoric acid. Included are salts of formula (2) with organic sulfonic acids such as p-toluenesulfonic acid and other acids known and used in the cephalosporin art.

Rが水素である式■の物質は金属塩も形成する。合成上
適切な金属塩にはナトリウム、カリウム、マグネシウム
、アルミニウム及び亜鉛が包含される。
Substances of formula (3) in which R is hydrogen also form metal salts. Synthetically suitable metal salts include sodium, potassium, magnesium, aluminum and zinc.

本発明の最も好ましい化合物は: 1、ジフェニルメチル7β−アミノ−3−〔(Z)−1
−プロペン−1−イル〕−3−セフェム−4−カルボキ
シレート、 2、ジフェニルメチル7β−アミノ−3−〔(Z)−1
−プロペン−1−イル〕−3−セフェム−4−カルボキ
シレート−塩酸塩、 3、ジフェニルメチル7β−アミノ−3−((2)−1
−プロペン−1−イル〕−3−セフェム−4−カルボキ
シレ−ト・硫酸塩、 4.7β−アミノ−3−C(Z)−1−プロペン−1−
イル〕−3−セフェム−4−カルボン酸ナトリウム、5
゜ 7β−アミノ−34(Z)−1−プロペン−1−イ
ル〕−3−セフェム−4−カルボン酸カリウム、及び6
.7β−アミノ−3−〔(Z)−1−プロペン−1−イ
ルクー3−セフェム−4−カルボン酸 である。
The most preferred compounds of the invention are: 1. diphenylmethyl 7β-amino-3-[(Z)-1
-propen-1-yl]-3-cephem-4-carboxylate, 2, diphenylmethyl 7β-amino-3-[(Z)-1
-propen-1-yl]-3-cephem-4-carboxylate-hydrochloride, 3, diphenylmethyl 7β-amino-3-((2)-1
-propen-1-yl]-3-cephem-4-carboxylate sulfate, 4.7β-amino-3-C(Z)-1-propene-1-
Sodium yl]-3-cephem-4-carboxylate, 5
゜ Potassium 7β-amino-34(Z)-1-propen-1-yl]-3-cephem-4-carboxylate, and 6
.. 7β-Amino-3-[(Z)-1-propen-1-ylcu-3-cephem-4-carboxylic acid.

く態様の詳細六記載〉 第二の態様では、本発明は式lの化合物の製造方法に関
する。好ましい製造例は反応式1及び2に示されている
DETAILED DESCRIPTION OF THE EMBODIMENTS In a second aspect, the present invention relates to a method for preparing a compound of formula I. Preferred production examples are shown in Reaction Schemes 1 and 2.

反応式1では、ジフェニルメチル基が好ましいカルボン
酸保護基として示しておる。当業界周知の他のカルボン
酸保護基が使用出来ることは当業者にとって明らかなこ
とであろう。
In Reaction Scheme 1, diphenylmethyl group is shown as a preferred carboxylic acid protecting group. It will be apparent to those skilled in the art that other carboxylic acid protecting groups well known in the art can be used.

アセトアルデヒドを用いる弐■の化合物のウィツテイヒ
反応では、適切なハロゲン化リチウム例えば塩化リチウ
ム、臭化リチウム又は沃化リチウムの添加が反応生成物
I[aの収率及びZ/Eの異性体比を増加させることが
見出された。
In the Witzteig reaction of compound 2 with acetaldehyde, the addition of a suitable lithium halide, such as lithium chloride, lithium bromide or lithium iodide, increases the yield of the reaction product I[a and the isomer ratio Z/E. It was found that

この反応は好ましくは、5乃至15化学当量の、好まし
くは10当量の臭化リチウムを用いて実施する。
This reaction is preferably carried out using 5 to 15 chemical equivalents of lithium bromide, preferably 10 equivalents.

メチレンクロライドが好ましい反応溶媒であシ、好まし
くはメチレンクロライド1部当り容積で約1/10乃至
p3部の、小比率の共溶媒例えばジメチルホルムアミド
又はイソプロパ〕−ルを含有する◇反応温度は一10℃
乃至+25℃の範曲が相応しく、0℃乃至25℃が好ま
しい。ウィツテイヒ生成物1mを適切な有機溶媒例えば
酢酸エチル中へと抽出し、抽出物をジラール試薬Tを用
いて処理して不発用の7−アミノセフ−3−エム化合物
、laとする。
Methylene chloride is the preferred reaction solvent, preferably containing a small proportion of a co-solvent such as dimethylformamide or isopropyl, about 1/10 to 3 parts by volume per part of methylene chloride. ℃
A range from 0°C to +25°C is suitable, with 0°C to 25°C being preferred. 1m of the Wittstein product is extracted into a suitable organic solvent such as ethyl acetate and the extract is treated with Girard's reagent T to give the dud 7-aminocef-3-em compound, la.

製造例3参照。次にIaをトリフルオロ酢酸(TFA)
で処理し、Z/E=971の比で7β−アミノ−3−〔
(Z)−1−プロペン−1−イルクー3−セフェム−4
−カルボン酸(Ib、製造例7)を得る0従来の酸クロ
ライド法又は活性化エステル法による、p−ヒドロキシ
フェニルグリシンを用いるIbのアシル化で米国特許第
4,520,022号の経口的に有効麦セファロスポリ
ン■を得る。
See Production Example 3. Then Ia was converted into trifluoroacetic acid (TFA)
7β-amino-3-[
(Z)-1-propene-1-ircu-3-cephem-4
-Acylation of Ib with p-hydroxyphenylglycine by conventional acid chloride method or activated ester method to obtain carboxylic acid (Ib, Preparation Example 7) of U.S. Pat. No. 4,520,022 orally. ■ Obtain effective wheat cephalosporin.

第二の反応式では、7β−アミノ−3−プロペン−1−
イルセファロスポリンエステルIa ヲN −Boe 
(tart −ブトキシカルボニル)で保護したp−ヒ
ドロキシフェニルグリシンを用いる、DCC(ジシクロ
へキシルカルボジイミド)の共存下でアシル化し、次に
TFA ()リフルオロ酢酸)を用いた脱保護によって
もセファロスポリンVが得られる。
In the second reaction scheme, 7β-amino-3-propene-1-
Ilcephalosporin ester Ia woN-Boe
Cephalosporin is obtained.

特定の態様の記載 実験的製造例中に現われる次の略号は下記の意味を有す
る。
The following abbreviations that appear in the Description of Specific Embodiments and Experimental Preparation Examples have the following meanings.

Ph=フェニル BOC= −COOC(CHs)s DCC=ジシクロへキシルカルボジイミドTFA  =
  )リフルオロ酢酸 EtOAc=酢酸エチル DMF  =ジメチルホルムアミド ツ           8 目           −… 製造例 1 一トクロライド CH,C1,(940−)中のジフェニルメチル7−ア
ミノ−3−クロロメチル−3−セフェム−4−カルボキ
シレート・塩酸!(200f、0.44モル)の懸濁体
にINNa(440m)を室温で加えた。混合物を10
分間振盪して有機層をわけとった。この有機層にMgS
O4(75f )及びベンズアルデヒド(519,0,
48モル)を加え、混合物を室温で3時間静置した。反
応混合物を濾過し、不溶分をcn、cz雪 (200−
)で洗浄した。合併しfcP液と洗液ニトリフェニルホ
スフィン(126f、0.48モル)を加えた。混合物
を減圧下で約400mに濃縮して、4日間静置したり得
られた粘稠油状物を酢酸エチル(1t)で稀釈、摩砕し
て表記化合物、淡黄色結晶性粉末を分離し、これを濾過
により蒐集し真空乾燥した。収量3229 (96チ)
。m、p、185〜190℃(分解)。
Ph=phenyl BOC= -COOC(CHs)s DCC=dicyclohexylcarbodiimide TFA=
) Rifluoroacetic acid EtOAc = ethyl acetate DMF = dimethylformamide 8 -... Production example 1 diphenylmethyl 7-amino-3-chloromethyl-3-cephem-4-carboxy in monotochloride CH, C1, (940-) Rate hydrochloric acid! INNa (440 m) was added to a suspension of (200 f, 0.44 mol) at room temperature. mix 10
The organic layer was separated by shaking for a minute. MgS in this organic layer
O4 (75f) and benzaldehyde (519,0,
48 mol) was added and the mixture was allowed to stand at room temperature for 3 hours. The reaction mixture was filtered and the insoluble matter was removed by cn, cz snow (200-
). The combined fcP solution and washing solution nitriphenylphosphine (126f, 0.48 mol) were added. The mixture was concentrated to about 400 m under reduced pressure and allowed to stand for 4 days, and the resulting viscous oil was diluted with ethyl acetate (1 t) and triturated to separate the title compound, a pale yellow crystalline powder. This was collected by filtration and vacuum dried. Yield 3229 (96 chi)
. m, p, 185-190°C (decomposition).

I R: νKBrcm−”  1780.1720.
1630゜ax IJ■:2”””nm(g)  260(24100)
IR: νKBrcm-” 1780.1720.
1630゜ax IJ■: 2"""nm (g) 260 (24100)
.

ax 製造例 2 CH鵞C4(1,6t) 中のジフェニルメチル7−ペ
ンジリデンアミノー3−トリフェニルホスホニオメチル
−3−セフェム−4−カルボキシレートクロライド(3
229,0,42モル)及び5 N NaICOs (
252fRt)の混合物を15分間室温で激しく攪拌し
た。有機層をわけと9、MgSO4で乾燥して約500
−の容極に#給した。濃縮物を攪拌しつつアセトン(1
t)で稀釈して淡黄色結晶性粉末としこれを濾過により
蒐集して1.融点195〜198℃(分解)のm237
t (78%)を得た。
ax Production Example 2 Diphenylmethyl 7-penzylideneamino-3-triphenylphosphoniomethyl-3-cephem-4-carboxylate chloride (3
229,0,42 mol) and 5 N NaICOs (
252fRt) was stirred vigorously for 15 minutes at room temperature. Separate the organic layer and dry with MgSO4 to about 500%
− was given # to the extreme. Acetone (1
t) to obtain a pale yellow crystalline powder, which was collected by filtration.1. m237 with melting point 195-198°C (decomposed)
t (78%) was obtained.

IR:l””r51−”  1770.1620.。IR:l""r51-" 1770.1620..

ax Uv:λCH1c”  nm(g)  254(230
00)、 389ax (22000)。
ax Uv:λCH1c” nm (g) 254 (230
00), 389ax (22000).

NMR:δcDc′s ppm  z、s6及び3.1
6(2H,ABq)、5.00 (IH,d、J =4
Hz )、 5.23 (IH%d。
NMR: δcDc's ppm z, s6 and 3.1
6 (2H, ABq), 5.00 (IH, d, J = 4
Hz), 5.23 (IH%d.

J=4Hz)、 5.47 (IH%d、J=22Hz
)、6.95 (IH%g)、 7.2〜7.8 (3
0H,m )、8.55(IH,s)。
J=4Hz), 5.47 (IH%d, J=22Hz
), 6.95 (IH%g), 7.2-7.8 (3
0H,m), 8.55 (IH,s).

製造例 3 塩酸塩(Iaの塩酸塩) 無水のジメチルホルムアミド(100xg)及びCH!
 C2x(300xg)の混合溶媒中のLiBr  (
19t、216ミリモル)の冷溶液に、アセトアルデヒ
ド(2(ld、360ミリモル)とジフェニルメチル7
−ペンジリデンアミノー3−(()リフェニルホスホラ
ニリデン)メチル)−3−セフェム−4−カルホキシレ
ー) ([1)(14M、20ミリモル)を−5℃で加
えた。混合物を一5℃〜−10℃に20時間、次に室温
に5時間、静置した。生成した淡褐色溶液を約100−
の容積に真空濃縮して、酢酸エチル(40〇−)とH雪
0  (400d)の2層溶媒に加えた。上層をわけと
ってイソプロピルエーテル(400d)で稀釈した0シ
リカゲル(和光ゲルc−xao、40t)を混合物に加
えた。混合物を5分間振盪して珪藻土濾過助剤パッドで
濾過した。不溶分を酢酸エチル−イソプロピルエーテル
の混合溶媒(l/1.200m)を用いて洗浄した。合
併したP液と洗液を約400−の容積に濃縮した。0.
5Mジラール試薬Tメタノール溶液(60mj)及び酢
酸(6−)を上記濃縮物に加えて、混合物を15分間室
温で攪拌した。混合物を蒸発させて約200−の容積と
し、H雪0(200m)、飽和NaHCOs水溶液(3
X20m)及びブライン(20d)を用いて順次に洗浄
し、Mg S o、で乾燥、活性炭で処理して、約50
−に濃縮した。濃縮物にメタノール(6〇−)中の1規
定HCjを室温で加えて15分間放置した。
Production Example 3 Hydrochloride (hydrochloride of Ia) Anhydrous dimethylformamide (100xg) and CH!
LiBr (
Acetaldehyde (2 (ld, 360 mmol)) and diphenylmethyl 7
-penzylideneamino-3-(()liphenylphosphoranylidene)methyl)-3-cephem-4-carboxyle) ([1) (14M, 20 mmol) was added at -5<0>C. The mixture was left at -5°C to -10°C for 20 hours and then at room temperature for 5 hours. The resulting light brown solution was heated to about 100-
It was concentrated in vacuo to a volume of 200 ml and added to a two-layer solvent of ethyl acetate (400 d) and H snow 0 (400 d). The upper layer was separated and 0 silica gel (Wako Gel C-XAO, 40t) diluted with isopropyl ether (400d) was added to the mixture. The mixture was shaken for 5 minutes and filtered through a diatomaceous earth filter aid pad. Insoluble matter was washed with a mixed solvent of ethyl acetate-isopropyl ether (1/1.200 m). The combined P solution and wash solution were concentrated to a volume of approximately 400-mL. 0.
5M Girard reagent T in methanol (60mj) and acetic acid (6-) were added to the above concentrate and the mixture was stirred for 15 minutes at room temperature. The mixture was evaporated to a volume of approximately 200 m, H snow 0 (200 m), saturated NaHCOs aqueous solution (3
x 20m) and brine (20d), dried over MgSO, treated with activated carbon,
- Concentrated to -. 1N HCj in methanol (60-) was added to the concentrate at room temperature and allowed to stand for 15 minutes.

混合物を蒸発させて約30艷にし、エーテル(300m
)を加えて稀釈した。沈澱をP?4により蒐年し、p、
 O,上で乾燥して7.99の淡黄色粉末を得た。メタ
ノール(80+d)と酢酸エチル(80m)の混合溶媒
中の粉末(7,3f)の溶液を活性炭で処理し、約10
0−に濃縮し、標記化合物の結晶性塩酸塩を種結晶とし
て加え、エーテル(80d)でゆつくシと稀釈し、1時
間攪拌した。分離した結晶を濾過により蒐集し、p、 
O,上で真空乾燥して6.:1l(71%)の標記化合
物を得た。この生成管は3位置のプロペニル部分に関し
て異性体2及びEの混合物である。(HPLCによりZ
/E=9/1)(リクロソルブ[Lichrosorb
 ]RP−18,80qbメタノール−pH7,2燐酸
塩緩衝液、254 n m、 1 dlwk )。
The mixture was evaporated to about 30 m
) was added to dilute it. P for precipitation? 4, p.
Drying over O.G. gave a pale yellow powder of 7.99%. A solution of the powder (7,3f) in a mixed solvent of methanol (80+d) and ethyl acetate (80m) was treated with activated carbon to give about 10
The crystalline hydrochloride of the title compound was added as seed crystals, slowly diluted with ether (80d), and stirred for 1 hour. Collect the separated crystals by filtration, p.
6. Vacuum dry on O. :1 liter (71%) of the title compound was obtained. This product tube is a mixture of isomers 2 and E for the propenyl moiety in the 3 position. (Z by HPLC
/E=9/1) (Lichrosorb
]RP-18,80qb methanol-pH 7,2 phosphate buffer, 254 nm, 1 dlwk).

I R: v KBrctm−”  2850.178
5.1725.。
IR: v KBrctm-” 2850.178
5.1725. .

m&X UR:λmaxn m (E”r 二) 287 (1
73)。
m&X UR:λmaxn m (E”r 2) 287 (1
73).

EtO)l NMR:δDMSO−” ppm 1.47 (27/
IOH,d−d、J=7.2Hz、=CHCH3、ci
s)、 1.74 (3/10H%d、J=7Hz、=
CHCHs、trans )、 3.47及び3,8(
各IH%d%J=16Hz)、 5.13(IH。
EtO)l NMR: δDMSO-” ppm 1.47 (27/
IOH, dd, J=7.2Hz, =CHCH3, ci
s), 1.74 (3/10H%d, J=7Hz, =
CHCHs, trans ), 3.47 and 3,8 (
Each IH%d%J=16Hz), 5.13(IH.

d、 J=4.5Hz、6−H)、 5.23(1)(
、d、J=4.5Hz、 7−H)、5.62(IH,
d−q、 、T−10及び7Hz、3−CH=CH)、
 6.24 (IH,d−d。
d, J=4.5Hz, 6-H), 5.23(1)(
, d, J=4.5Hz, 7-H), 5.62(IH,
d-q, , T-10 and 7Hz, 3-CH=CH),
6.24 (IH, d-d.

J=10及び2Hz、3−CH)、 6.81 (IH
,s。
J=10 and 2Hz, 3-CH), 6.81 (IH
,s.

CHPH鵞)、 7.35 (IOH%m%Ph  H
) 。
CHPH), 7.35 (IOH%m%Ph H
).

製造例 4 H2O(20d)及び酢醗エチル(40m)中のジフェ
ニルメチル7−アミノ−3−〔(Z)−1−プロペン−
1−イル)−3−セフェム−4−カルボキシレートの塩
酸塩(5f、11.31モル)の攪拌懸濁体に、混合物
のpHが8となる迄、NaHCOsを加えた。有機層を
飽和NaCj水溶液(5−)で洗浄し、Mg S 04
で乾燥して約20−の容積に濃縮した。得られた溶液を
イソプロピルエーテル(10m)で稀釈して結晶性化合
物1mの種を入れ六〇さらにイソプロピルエーテル(3
0m)を混合物を攪拌しつつゆっくりと加えた015分
後、分離した無色結晶をF″過により蒐集し、イソプロ
ピルエーテル(10d)で洗浄L、P2O6上で真空乾
燥して4.3f(94%)の標記化合物(HPLCでZ
/E=9/1 )を得た。(リクロソルブRP−18,
80チメタノールーpH7,2燐酸塩緩衝液、254n
m、lsd/”)。
Preparation Example 4 Diphenylmethyl 7-amino-3-[(Z)-1-propene- in H2O (20d) and ethyl vinegar (40m)
To a stirred suspension of the hydrochloride salt of 1-yl)-3-cephem-4-carboxylate (5f, 11.31 mol) was added NaHCOs until the pH of the mixture was 8. The organic layer was washed with saturated NaCj aqueous solution (5-) and MgSO4
and concentrated to a volume of approximately 20 cm. The resulting solution was diluted with isopropyl ether (10 m), seeded with 1 m of the crystalline compound, and further diluted with isopropyl ether (3 m).
After 15 minutes, the separated colorless crystals were collected by F'' filtration, washed with isopropyl ether (10d), and vacuum dried over P2O6 to give 4.3f (94%). ) title compound (Z by HPLC)
/E=9/1) was obtained. (Licrosolve RP-18,
80 timetanol pH 7,2 phosphate buffer, 254n
m,lsd/”).

I R: uKB’ ear−” 3450.1765
.1730゜ax Uv:λF′t0Hnm (E:り 289(185)
IR: uKB'ear-" 3450.1765
.. 1730°ax Uv:λF't0Hnm (E:ri 289 (185)
.

ax NMR:δCDCt” ppm  1.43 (3H%
d−d、J=2及び7Hz、 CH==cl(CHs)
、 1.66 (2H1br、 s、D!Oにより消失
、NMR)、 3.23及び3.55(各IH,d、J
=17Hz、 2−H)、4.73(IHld、J=4
.5Hz、 6−H)、 4.96 (IH,d、 J
=4.5Hz、7−H)、 5.46 (IH,ci−
q、J=10及び7Hz、3−CH=CH)、 6.0
6 (IH,br。
ax NMR: δCDCt” ppm 1.43 (3H%
dd, J=2 and 7Hz, CH==cl(CHs)
, 1.66 (2H1br, s, disappeared by D!O, NMR), 3.23 and 3.55 (each IH, d, J
=17Hz, 2-H), 4.73(IHld, J=4
.. 5Hz, 6-H), 4.96 (IH, d, J
=4.5Hz, 7-H), 5.46 (IH, ci-
q, J=10 and 7Hz, 3-CH=CH), 6.0
6 (IH, br.

d%J−10Hz、3=CJH、6,94(IH,a、
C旦ph、)、7.3 (IOHlm、 Ph H) 
d%J-10Hz, 3=CJH, 6,94(IH, a,
Cdanph, ), 7.3 (IOHlm, Ph H)
.

製造例 5 酢酸エチル(104m)中のジフェニルメチル7−アミ
ノ−3−〔(Z)−1−プロペン−1−イル)−3−セ
フェム−4−カルホキシレー)(Ia)(4,2g、1
0.4ミリモル)、(D)−α−(t−ブトキシカルボ
ニルアミノ)−α−(4−ヒドロキシフェニル)酢@ 
(3,3f、12.5ミリモル)及びDCC(2,6t
、12.5ミリモル)の混合物を1.5時間、室温で攪
拌した。混合物をr過し、不溶分を酢酸エチル(20d
)r洗浄した。P液及び洗液を合併して、飽和NaHC
Os水溶液(3X5m)、ブライン(5−)、lO−H
Ct(5m)及びブラインの順で洗浄し、Mg S 0
4で乾燥し、活性炭で処理してr過した。V液を約10
−に濃縮し、n−へブタン(20gg)で稀釈した。沈
殿をr過により蒐集し、P、 Os上で真空乾燥した。
Preparation Example 5 Diphenylmethyl 7-amino-3-[(Z)-1-propen-1-yl)-3-cephem-4-carboxylene) (Ia) (4.2 g, 1
0.4 mmol), (D)-α-(t-butoxycarbonylamino)-α-(4-hydroxyphenyl) vinegar @
(3,3f, 12.5 mmol) and DCC (2,6t
, 12.5 mmol) was stirred for 1.5 hours at room temperature. The mixture was filtered and the insoluble matter was removed with ethyl acetate (20 d
)r Washed. The P solution and washing solution were combined and saturated NaHC
Os aqueous solution (3X5m), brine (5-), lO-H
Washed with Ct (5 m) and brine, MgSO
4, treated with activated carbon and filtered. Approximately 10% V liquid
- and diluted with n-hebutane (20 gg). The precipitate was collected by filtration and vacuum dried over P, Os.

無色の粉末(HPLCにもとづきZ/E=971 )と
して収量7.8F(90%純度、重トチ定量的)(’)
loフルブRP−18,80%メタノール−pH7,2
燐酸塩緩衝液、254nm・1−/sb )。
Yield 7.8F (90% purity, heavy weight quantitative) (') as a colorless powder (Z/E=971 based on HPLC)
lo Fulv RP-18, 80% methanol-pH 7,2
phosphate buffer, 254 nm·1−/sb).

@   KBr   −1 1R0ν   cs  3400、1790. 172
0,1690゜ax tOH Uv:λm、xn m (E −h ! ) 278 
(113)、289(115)、 295(95)。
@ KBr -1 1R0ν cs 3400, 1790. 172
0,1690゜ax tOH Uv: λm, xn m (E-h!) 278
(113), 289(115), 295(95).

NMR:δCD” ppm 1.3−1.45 (12
H1m、 BOC−H及び=CH−CH)、 3.08
及び3.33(各IH1d、J=18Hz、2−H)、
 4.92 (IH,d、 J=4.5Hz、 6−H
)、 5.06 (IH%d、 J=51(z、 D2
0添加で、8、CHN)、 5.5(IH%d−q%J
=10及び7Hz、3−CH=CH)、 5.68 (
IH,d−d。
NMR: δCD” ppm 1.3-1.45 (12
H1m, BOC-H and =CH-CH), 3.08
and 3.33 (each IH1d, J=18Hz, 2-H),
4.92 (IH, d, J=4.5Hz, 6-H
), 5.06 (IH%d, J=51(z, D2
0 addition, 8, CHN), 5.5 (IH%d-q%J
=10 and 7Hz, 3-CH=CH), 5.68 (
IH, d-d.

J=4.5及び8Hz %DB O添加で、d s J
 ” 4−5 Hz 。
J = 4.5 and 8 Hz with % DBO addition, d s J
” 4-5 Hz.

6.71(IH%d、J=8Hz、010で消失、7−
NH)、6゜88(IHls、CHPh、)、 7.3
 (IOHlIn。
6.71 (IH%d, J=8Hz, disappears at 010, 7-
NH), 6°88 (IHLs, CHPh, ), 7.3
(IOHlIn.

ph−且)。ph- and).

製造例 6 製造例5で製造したジフェニルメチル?−((t))−
α−(t−ブトキシカルボニルアミノ)−α−(4−ヒ
ドロキシフェニル)アセトアミド)−a−((z)−x
−プロペン−1−イル)−3−セフェム−4−カルボキ
シレート(IV)(90チ純度、7.7 f、 10.
6ミリモル)、アニソール(7,7m)及びトリフルオ
ロ酢酸(77d)の混合物を1時間、室温で攪拌した。
Production Example 6 Diphenylmethyl produced in Production Example 5? -((t))-
α-(t-butoxycarbonylamino)-α-(4-hydroxyphenyl)acetamide)-a-((z)-x
-propen-1-yl)-3-cephem-4-carboxylate (IV) (90% purity, 7.7 f, 10.
6 mmol), anisole (7.7m) and trifluoroacetic acid (77d) was stirred for 1 hour at room temperature.

混合物を真空濃縮した。トルエン(50d)を濃縮物に
添加して混合物を真空蒸発させた。エーテル(200m
)を残渣油状物に加えた。分離した固体を濾過により蒐
集し、エーテル(20mg)で洗浄し、KOH上で真空
乾燥して5.3tのBMY−28100のトリフルオロ
酢酸(TFA)塩を得た。この塩(5,:l)をH,0
(10(ld)に溶解し、活性炭で処理してダイアイオ
ン(Diaion)HP−20(0,6t)を充填し九
カラム上にのせた。カラムをH,0(4t)で洗浄し、
409G水性M@OHで溶離させた。所望生成物を含む
メタノール性フラクション(1,71)を蒐集して、約
20−の容積に蒸発させ喪。濃縮物をゆっくりとアセト
ン(100+sg)で稀釈した。分離した無色の結晶性
粉末を濾過により蒐集して、アセトン(20m)で洗浄
し、p、 O,上で真空乾燥して4t(97チ)のBM
Y−28100(ZE=9/1、双性イオン)(リクロ
ソルブRP−18,20%メタノール−PH7,2燐酸
塩緩衝液、254nm、1−7m )を得た0製造例 
7 0℃に冷却しfc260−アニソールと1.381のト
リフルオロ酢酸(TFA)の攪拌溶液に、149.7(
0,338モル)のジフェニルメチル7−アミノ−3−
〔(Z)−1−フロペン−1−イル〕−3−セフェム−
4−カルボキシレート・塩酸塩(0,338モル、製造
例3又は11)を加えた。大部分の過剰なTFAをロー
タリーエバポレータで真空除去した。残留上澄み溶液を
デカンテーションして、残漬スラリーを1.5tの無水
エーテルと1時間摩砕した。
The mixture was concentrated in vacuo. Toluene (50d) was added to the concentrate and the mixture was evaporated in vacuo. Ether (200m
) was added to the residual oil. The separated solid was collected by filtration, washed with ether (20 mg), and dried in vacuo over KOH to yield 5.3 t of the trifluoroacetic acid (TFA) salt of BMY-28100. This salt (5,:l) is H,0
Diaion HP-20 (0,6 t) was dissolved in H, 10 (ld) and treated with activated carbon and loaded onto a nine column. The column was washed with H,0 (4 t);
Eluted with 409G aqueous M@OH. The methanolic fraction (1,71) containing the desired product was collected and evaporated to a volume of approximately 20 cm. The concentrate was slowly diluted with acetone (100+sg). The separated colorless crystalline powder was collected by filtration, washed with acetone (20 m), and dried under vacuum over P,O, to give 4 t (97 m) of BM.
0 production example yielding Y-28100 (ZE=9/1, zwitterion) (Licrosolve RP-18, 20% methanol-PH7,2 phosphate buffer, 254 nm, 1-7m)
7. To a stirred solution of fc260-anisole and 1.381 trifluoroacetic acid (TFA) cooled to
0,338 mol) of diphenylmethyl 7-amino-3-
[(Z)-1-flopen-1-yl]-3-cephem-
4-carboxylate hydrochloride (0,338 mol, Preparation Example 3 or 11) was added. Most of the excess TFA was removed in vacuum on a rotary evaporator. The remaining supernatant solution was decanted and the remaining slurry was triturated with 1.5 t of anhydrous ether for 1 hour.

結晶性生成物を2iし、P、0.で乾燥して87.24
9のIbのトリフルオロ酢酸塩を得た。この87.24
9のトリフルオロ酢酸塩を900dの水中に懸濁させて
攪拌した( pH約2.5)。混合物を+5℃に冷却し
て12NHctを用いてpH0,6に調節した。黄色溶
液を活性炭処理して、スラリーを珪藻土濾過助剤パッド
で濾過した。得られた溶液を+5℃に冷却して20%N
aOHを用いてpHを2.0に調節した。懸濁液を1時
間冷蔵庫中に保持して結晶化を助長した。結晶を蒐集し
、800−の水、800−のアセトンで洗浄して室温で
真空乾燥した。収量69.4f(85,5%)(カラム
RP18メルク[:MERCK); 0.IM Hz(
N)切PO495d+CH3CN  5d; 290n
mで検出のHPLCによると)9.7%のtrans異
性体を含有。
The crystalline product was 2i, P, 0. Dry with 87.24
The trifluoroacetate of Ib of 9 was obtained. This 87.24
The trifluoroacetate of No. 9 was suspended in 900 d of water and stirred (pH approximately 2.5). The mixture was cooled to +5°C and adjusted to pH 0.6 using 12NHct. The yellow solution was treated with activated carbon and the slurry was filtered through a diatomaceous earth filter aid pad. The resulting solution was cooled to +5°C and 20% N
The pH was adjusted to 2.0 using aOH. The suspension was kept in the refrigerator for 1 hour to promote crystallization. The crystals were collected, washed with 800% water and 800% acetone, and dried under vacuum at room temperature. Yield 69.4f (85.5%) (column RP18 Merck [:MERCK); 0. IM Hz (
N) Cut PO495d+CH3CN 5d; 290n
Contains 9.7% trans isomer (according to HPLC detected at m).

製造例 8 7−アミノ−3−〔(Z)−1−プロペン−1−イル)
−CH2C4(500m )中の製造例2で製造したホ
スホラニル化合物III (50,Of、 68.7ミ
リモル)の溶液を、少量のCH,C1,(10d)を含
む無水DMF (170++l)中の臭化リチウム(2
9,8F、343ミリモル)と、そして次に、(エヌ・
エル・ドレーク及びジー・ビー・クック、オーガニック
・シンセシス・コレクティブ・ボリウム(N、 L、 
Drake  and G、 B、 Cooke、 O
rg、 Syn、 Cot。
Production example 8 7-amino-3-[(Z)-1-propen-1-yl)
A solution of the phosphoranyl compound III prepared in Preparation Example 2 (50, Of, 68.7 mmol) in -CH2C4 (500 m) was brominated in anhydrous DMF (170++ l) containing a small amount of CH,C1, (10d). Lithium (2
9,8F, 343 mmol) and then (N.
Elle Drake and G.B. Cook, Organic Synthesis Collective Volume (N, L,
Drake and G, B, Cooke, O
rg, Syn, Cot.

Vol、)第■巻、第407負の方法に従ってパラアル
デヒドとトルエンスルホン酸から蒸留によって製造した
)無水アセトアルデヒド(39m、687ミリモル)と
混合した。
Vol.) Volume 1, No. 407 Negative method) was mixed with anhydrous acetaldehyde (39m, 687 mmol) prepared by distillation from paraaldehyde and toluenesulfonic acid according to the negative method.

混合物を密封容器に入れて、20℃に2日間保った。反
応混合物を蒸発させ゛乙残留液体をEtOAe  (8
00sOで稀釈し、水(3X300m)及び飽和Na 
CL浴溶液300d)で洗浄し、蒸発させて泡沫状固体
(34?)として検診しである3−プロペニル誘導体1
1aを得、とわを更に精製すること無しに次の反応に使
用した。
The mixture was placed in a sealed container and kept at 20°C for 2 days. The reaction mixture was evaporated and the remaining liquid was diluted with EtOAe (8
Diluted with 00sO, water (3X300m) and saturated Na
The 3-propenyl derivative 1 was washed with CL bath solution 300d) and evaporated as a foamy solid (34?).
1a was obtained and used in the next reaction without further purification.

上で得た粗製ITaを室温で1時間、98%ギ酸(35
d)及び濃HCt (17d、206ミリモル)で処理
した。反応混合物に水(350m)を加えて油状層を分
離させ、これをEtOAe (3X100m)で洗い去
った。水層のpHを4NNaOH(約65wIt)を用
いて約3に攪拌下で調整して、結晶性固体を生じさせ、
これをt過により蒐集して水(50d)で洗浄して標記
化合物(Ib、9.72.59%)を得た。HPLC(
リクロソルブRP−18,4X300■、Me OH:
燐酸塩緩衝液(pH7)=15:85)tj、この生成
物が3−プロペニル基の二重結合について2及びE異性
体の83:17混合物であることを示していた。
The crude ITa obtained above was treated with 98% formic acid (35%
d) and concentrated HCt (17d, 206 mmol). Water (350m) was added to the reaction mixture to separate the oily layer, which was washed away with EtOAe (3X100m). adjusting the pH of the aqueous layer to about 3 using 4N NaOH (about 65 wIt) under stirring to produce a crystalline solid;
This was collected by filtration and washed with water (50d) to obtain the title compound (Ib, 9.72.59%). HPLC (
Licrosolve RP-18, 4X300■, Me OH:
Phosphate buffer (pH 7) = 15:85)tj, indicating that the product was an 83:17 mixture of 2 and E isomers for the double bond of the 3-propenyl group.

m、p、200℃(分解)0 I R: v    (KBr) cm   3420
、1085、ax 1620゜ Uv:λ   (pH7燐酸塩緩衝液)nm(リ 28
3ax (8900)。
m, p, 200℃ (decomposition) 0 I R: v (KBr) cm 3420
, 1085, ax 1620°Uv:λ (pH 7 phosphate buffer) nm (Li 28
3ax (8900).

NMR:δ(DzO+NaHCOs) pprn  1
.69及び1.88(3H1各d、J=6.0Hz、−
CH=CH−CH3のZ及びE)、 3.38及び3.
72(2H%Abq、J=17Hz、H−2)、 5.
18 (IH,d、 J、  、 ==5.0Hz、 
H−6)、5.51 (IHld、 H−7)、約5.
8 (IHlm、 −CH=CH−CH3)  及び 
6.06(IHldlJ”11Hz、−CH=CHCH
3)。
NMR: δ(DzO+NaHCOs) pprn 1
.. 69 and 1.88 (3H1 each d, J = 6.0Hz, -
CH=CH-CH3 Z and E), 3.38 and 3.
72 (2H%Abq, J=17Hz, H-2), 5.
18 (IH, d, J, , ==5.0Hz,
H-6), 5.51 (IHld, H-7), approx.
8 (IHlm, -CH=CH-CH3) and
6.06 (IHldlJ"11Hz, -CH=CHCH
3).

元素分析: C16HBN203 Sとしての計算値:
 C149,99;H,5,03;N、11.66:S
、13.34%。
Elemental analysis: Calculated value as C16HBN203 S:
C149,99;H,5,03;N,11.66:S
, 13.34%.

実測値:C,50,20;H14,94;N、10.9
3;S、12,82チ。
Actual value: C, 50, 20; H14, 94; N, 10.9
3;S, 12,82ch.

製造例 9 7((D)−2−アミノ−2−(4−ヒドロキシフェニ
ル)製造例8で製造した化合物Ib(1,58f、6.
56ミリモル)の氷冷下のCH2Cl2  (16mj
)懸濁液にジメチルアニリン(1,7m、13.1ミリ
モル)、トリメチルシリルクロライド(2,1td、1
6.4ミリモル)及びトリエチルアミン(TEA、2.
3d、16.4ミリモル)の順で加えた。
Production Example 9 7((D)-2-amino-2-(4-hydroxyphenyl) Compound Ib (1,58f, 6.
56 mmol) of CH2Cl2 (16 mj
) dimethylaniline (1.7 m, 13.1 mmol), trimethylsilyl chloride (2.1 td, 1
6.4 mmol) and triethylamine (TEA, 2.
3d, 16.4 mmol) were added in this order.

混合物を室温で30分間攪拌した。この混合物に攪拌下
で少量宛D−p−ヒドロキシフェニルグリシルクロライ
ド・塩酸塩(1,46f、6.56ミリモル)を加え、
反応をHPLC(、リクロソルブRP −18,4X3
00m MeOH:燐酸塩緩衝液(pH7)=25ニア
5)によってモニターした。グリシルクロライドの追加
量を混合物に3回、15分間隔で(291岬宛)加えて
アシル化を完結させた0無水DMF(0,1m)を含む
無水MeOH(2,0m)を添加した徒、得られた透明
溶液をTEA(3,2d)を用いてpH6に中和し、次
にCH鵞C4(30ttt )で稀釈して沈殿を生じさ
せ、これを濾過により蒐集してCH*C1z  (10
m)で洗浄し、標記化合物をジメチルホルムアミド溶媒
和物として得々。(2,39f、収率94%;約50チ
純度;HPLCKjすZ/E=47:12)。
The mixture was stirred at room temperature for 30 minutes. To this mixture was added a small amount of D-p-hydroxyphenylglycyl chloride hydrochloride (1,46f, 6.56 mmol) under stirring,
The reaction was analyzed by HPLC (Licrosorb RP-18,4X3
Monitored by 00m MeOH:phosphate buffer (pH 7) = 25 nia 5). Additional amounts of glycyl chloride were added to the mixture three times at 15 minute intervals (to 291 Cape) to complete the acylation. The resulting clear solution was neutralized to pH 6 using TEA (3,2d) and then diluted with CH*C4 (30ttt) to produce a precipitate, which was collected by filtration and CH*C1z ( 10
m) to obtain the title compound as a dimethylformamide solvate. (2,39f, yield 94%; purity about 50%; HPLCKJZ/E = 47:12).

製造例 10 レート(K) MW= 758.8 18tのCC1a、 1.8tのメタノール及び12f
のp−ベンゾイル安息香酸の攪拌溶液を8℃に冷却し、
970−のアセトアルデヒドを加えた。得られた溶液の
温度は+14℃に上昇した。5分後、588t(0,7
749モル)のジフェニルメチル7−フェニルアセトア
ミド−3−(()リフェニルホスホラニリデン)メチル
〕−3−セフェム−4−カルボキシレートを加えたO冷
却浴を外して、混合物を透光しN3雰囲気下で、ホスホ
ランの完全溶解が起こる迄、4時間35℃で激しく攪拌
した。得られた溶液を真空濃縮して、残渣を2tのエタ
ノールに溶かし、その溶液を真空濃縮して半結晶化残渣
とし、これを3tのエタノールを用いてスラリー化した
。混合物を2時間+5℃で攪拌して、−晩装置し、結晶
を2回蒐集して、エタノールで洗浄し、室温で真空乾燥
した。収量191t(47%)a m−P。
Production example 10 Rate (K) MW = 758.8 18t CC1a, 1.8t methanol and 12f
A stirred solution of p-benzoylbenzoic acid was cooled to 8°C,
970-g of acetaldehyde was added. The temperature of the resulting solution rose to +14°C. After 5 minutes, 588t (0.7
749 mol) of diphenylmethyl 7-phenylacetamido-3-(()liphenylphosphoranylidene)methyl]-3-cephem-4-carboxylate was added. The O cooling bath was removed and the mixture was exposed to light and N3 atmosphere. The mixture was stirred vigorously at 35° C. for 4 hours until complete dissolution of the phosphorane occurred. The resulting solution was concentrated in vacuo, the residue was dissolved in 2 t of ethanol, the solution was concentrated in vacuo to a semi-crystalline residue, which was slurried with 3 t of ethanol. The mixture was stirred for 2 hours at +5° C., stored overnight, and the crystals were collected twice, washed with ethanol, and dried under vacuum at room temperature. Yield 191t (47%) a m-P.

124〜128℃、?、5%trans異性体を含む(
=’ルク社製のりクロソルブSi 60 5μmHPL
Pカラムを85%)ルエン、15%酢酸エチルで溶離し
て求め痴製造例 11゜ (1a) 2.8tのCHIC1雪中の159.7f(0,767
モル)のpct、の攪拌溶液に、280−のCH=C2
m中の56.7m(0,700モル)のピリジンを20
分間にわたって添加した。窒素雰囲気下でスラリーを2
℃に冷却しながら製造例10で製造した■の256t(
0,488モル)を加えた。
124-128℃,? , containing 5% trans isomer (
='Glue Closolv Si 60 5μmHPL manufactured by Luk Co., Ltd.
P column was eluted with 85%) toluene and 15% ethyl acetate.Production Example 11゜(1a)
pct, of 280- CH=C2
56.7m (0,700 mol) of pyridine in m is 20
Added over a period of minutes. Slurry under nitrogen atmosphere
256t of ■ produced in Production Example 10 while cooling to °C (
0,488 mol) was added.

混合物を40分間攪拌して、得られたスラリーを、−2
0℃の1.4tのCH鵞Ct雪及び209td(2,3
3モル)の1.3−ブタンジオールの激しく攪拌してい
る溶液に、温度を一5℃より上昇させない様に急速に住
人した。冷却浴を外して、45分後に温度を10℃に上
げて、この温度に35分間保った0水(1,(1)を加
えて攪拌を5分間続けると2層に分離した。有機層を6
00−の2NHCLと次に400−の飽和ブラインで洗
浄した。合併した水性抽出物(洗液)を2X600−の
CH,Ct、で逆洗して、そのCH,CL、  を当初
のCH,ct、抽出液に合併した。
The mixture was stirred for 40 minutes and the resulting slurry was
1.4t CH Goose Ct snow and 209td (2,3
3 mol) of 1,3-butanediol was added rapidly to a vigorously stirred solution without allowing the temperature to rise above -5°C. The cooling bath was removed, and after 45 minutes, the temperature was raised to 10 °C and kept at this temperature for 35 minutes. Water (1, (1)) was added and stirring was continued for 5 minutes to separate into two layers. The organic layer was separated into two layers. 6
Washed with 00-2N HCL and then 400-saturated brine. The combined aqueous extracts (washes) were backwashed with 2×600 − CH,Ct, and the CH,CL, was combined with the original CH,Ct, extract.

溶液を無水Mg S O,で乾燥した。Mg S 04
ス、ラリ−をr過して、Mg S O,を2X500づ
のcn2cz、で洗浄した。
The solution was dried with anhydrous Mg SO. Mg S 04
The slurry was filtered and the MgSO was washed with 2×500 ml of cn2cz.

合併しfcP液をロータリーエバポレータで2.4tの
容積に真空濃縮し、2.5tの酢酸エチルで稀釈した。
The combined fcP liquids were vacuum concentrated on a rotary evaporator to a volume of 2.4 t and diluted with 2.5 t of ethyl acetate.

溶液を貴び約1.3tの容積に濃縮した。生成した結晶
性スラリーをP過し、3X300−の酢酸エチルで洗浄
した。空気及びp、 0゜上での真空乾燥して、149
.8 tの標記化合物がベージュ色結晶として得られた
。収率69.3%。
The solution was concentrated to a volume of approximately 1.3 t. The resulting crystalline slurry was filtered and washed with 3×300 ethyl acetate. Air and p, vacuum drying above 0°, 149
.. 8t of the title compound was obtained as beige crystals. Yield 69.3%.

Claims (1)

【特許請求の範囲】 1、式: ▲数式、化学式、表等があります▼ 〔但し、3−プロペニル基はZ−配置を有しており、R
は水素又は通常のカルボン酸保護基である〕の化合物、
及びその酸付加塩及びRが水素である前記物質の金属塩
。 2、Rが水素、メトキシメチル、2,2,2−トリクロ
ロエチル、2−(トリメチルシリル)エチル、t−ブチ
ル、ベンジル、ジフェニルメチル、o−ニトロベンジル
、p−ニトロベンジル、トリメチルシリル、t−ブチル
ジメチルシリル、t−ブチルジフェニルシリル、アリル
及び2−クロロアリルより成る群から選ばれたものであ
る特許請求の範囲第1項記載の化合物及びその酸付加塩
。 3、酸付加塩が塩酸塩、硫酸塩、p−トルエンスルホン
酸塩及び燐酸塩より成る群から選ばれたものである特許
請求の範囲第2項記載の化合物。 4、金属塩がナトリウム、カリウム、カルシウム、又は
アルミニウム塩である特許請求の範囲第1項記載の化合
物。 5、ジフェニルメチル7β−アミノ−3−〔(Z)−1
−プロペン−1−イル〕−3−セフェム−4−カルボキ
シレート及びその塩酸塩である特許請求の範囲第2項記
載の化合物。 6、7β−アミノ−3−〔(Z)−1−プロペン−1−
イル〕−3−セフェム−4−カルボン酸及びその塩酸塩
である特許請求の範囲第2項記載の化合物。 7、7β−アミノ−3−〔(Z)−1−プロペン−1−
イル〕−3−セフェム−4−カルボン酸ナトリウムであ
る特許請求の範囲第4項記載の化合物。 8、式: ▲数式、化学式、表等があります▼ 〔但し、3−プロペニル基はZ−配置を有しており、R
は水素又は通常のカルボン酸保護基である〕の化合物、
及びその酸付加塩及びRが水素である前記物質の金属塩
の製造方法に於て、 式:▲数式、化学式、表等があります▼ 〔但し、Rは水素又は通常のカルボン酸保護基であり、
Phはフェニル基である〕の中間体を、ジクロロメタン
、N,N′−ジメチルホルムアミド、イソプロパノール
又はその混合物より成る不活性有機溶媒中で、0℃乃至
25℃の反応温度で、アセトアルデヒドと反応させて式
: ▲数式、化学式、表等があります▼ の化合物とし、且つその後ベンジリデン基又はベンジリ
デン基とカルボン酸保護基の両方を除去し、そして所望
によつては3−(Z)及び3−(E)異性体を分離する
ことを特徴とする式: ▲数式、化学式、表等があります▼ の化合物の製造方法。 9、アセトアルデヒドとの反応をハロゲン化リチウムの
共存下で実施する特許請求の範囲第8項記載の方法。 10、ハロゲン化リチウムが塩化リチウム、臭化リチウ
ム、又は沃化リチウムである特許請求の範囲第9項記載
の方法。 11、ハロゲン化リチウムが臭化リチウムである特許請
求の範囲第9項記載の方法。
[Claims] 1. Formula: ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [However, the 3-propenyl group has a Z-configuration, and R
is hydrogen or a conventional carboxylic acid protecting group,
and acid addition salts thereof and metal salts of said substances, wherein R is hydrogen. 2, R is hydrogen, methoxymethyl, 2,2,2-trichloroethyl, 2-(trimethylsilyl)ethyl, t-butyl, benzyl, diphenylmethyl, o-nitrobenzyl, p-nitrobenzyl, trimethylsilyl, t-butyldimethyl The compound according to claim 1 and its acid addition salt, which is selected from the group consisting of silyl, t-butyldiphenylsilyl, allyl and 2-chloroallyl. 3. The compound according to claim 2, wherein the acid addition salt is selected from the group consisting of hydrochloride, sulfate, p-toluenesulfonate and phosphate. 4. The compound according to claim 1, wherein the metal salt is a sodium, potassium, calcium, or aluminum salt. 5, diphenylmethyl 7β-amino-3-[(Z)-1
-propen-1-yl]-3-cephem-4-carboxylate and its hydrochloride. 6,7β-amino-3-[(Z)-1-propene-1-
yl]-3-cephem-4-carboxylic acid and its hydrochloride. 7,7β-amino-3-[(Z)-1-propene-1-
5. The compound according to claim 4, which is sodium [yl]-3-cephem-4-carboxylate. 8. Formulas: ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [However, the 3-propenyl group has a Z-configuration, and R
is hydrogen or a conventional carboxylic acid protecting group,
and its acid addition salts, and the method for producing metal salts of the above substances in which R is hydrogen: Formula: ▲ Numerical formula, chemical formula, table, etc. ▼ [However, R is hydrogen or a normal carboxylic acid protecting group. ,
Ph is a phenyl group] with acetaldehyde in an inert organic solvent consisting of dichloromethane, N,N'-dimethylformamide, isopropanol or mixtures thereof at a reaction temperature of 0°C to 25°C. Formula: ▲Mathical formula, chemical formula, table, etc.▼ and then remove the benzylidene group or both the benzylidene group and the carboxylic acid protecting group, and optionally convert 3-(Z) and 3-(E ) Formulas characterized by separating isomers: ▲There are mathematical formulas, chemical formulas, tables, etc.▼ Methods for producing compounds. 9. The method according to claim 8, wherein the reaction with acetaldehyde is carried out in the coexistence of lithium halide. 10. The method according to claim 9, wherein the lithium halide is lithium chloride, lithium bromide, or lithium iodide. 11. The method according to claim 9, wherein the lithium halide is lithium bromide.
JP61091419A 1985-04-22 1986-04-22 7-amino-3-propenylcephalosporanic acid and ester Granted JPS61249989A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72587185A 1985-04-22 1985-04-22
US725871 1985-04-22

Publications (2)

Publication Number Publication Date
JPS61249989A true JPS61249989A (en) 1986-11-07
JPH0327554B2 JPH0327554B2 (en) 1991-04-16

Family

ID=24916301

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61091419A Granted JPS61249989A (en) 1985-04-22 1986-04-22 7-amino-3-propenylcephalosporanic acid and ester

Country Status (38)

Country Link
JP (1) JPS61249989A (en)
KR (1) KR860008189A (en)
CN (1) CN1015714B (en)
AR (1) AR242581A1 (en)
AT (1) AT392072B (en)
AU (1) AU589170B2 (en)
BE (1) BE904646A (en)
CA (1) CA1273629A (en)
CH (1) CH671399A5 (en)
CS (1) CS270435B2 (en)
CY (1) CY1571A (en)
DD (1) DD244557A5 (en)
DE (1) DE3613365A1 (en)
DK (1) DK163584C (en)
EG (1) EG18001A (en)
ES (1) ES8800236A1 (en)
FI (1) FI84268C (en)
FR (1) FR2580652B1 (en)
GB (1) GB2173798B (en)
GR (1) GR861065B (en)
HK (1) HK106290A (en)
HU (1) HU195223B (en)
IE (1) IE59014B1 (en)
IT (1) IT1228241B (en)
LU (1) LU86402A1 (en)
MY (1) MY100694A (en)
NL (1) NL192205C (en)
NO (1) NO164659C (en)
NZ (1) NZ215717A (en)
OA (1) OA08245A (en)
PT (1) PT82436B (en)
SE (1) SE500217C2 (en)
SG (1) SG90890G (en)
SU (1) SU1435155A3 (en)
YU (1) YU43697B (en)
ZA (1) ZA862985B (en)
ZM (1) ZM4286A1 (en)
ZW (1) ZW9086A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118595A1 (en) * 2004-06-04 2005-12-15 Otsuka Chemical Co., Ltd. Process for production of 3-alkenylcephem compounds

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
US4870168A (en) * 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
DE3933934A1 (en) * 1989-10-03 1991-04-11 Bayer Ag METHOD FOR PRODUCING 7-AMINO-3 - ((Z) -1-PROPEN-1-YL) -3-CEPHEM-4-CARBONIC ACID
ATE201025T1 (en) * 1991-03-08 2001-05-15 Biochemie Gmbh METHOD FOR PRODUCING CEPHALOSPORINS AND INTERMEDIATE PRODUCTS IN THIS METHOD
AT399876B (en) * 1992-02-05 1995-08-25 Biochemie Gmbh Purificn. of 7-amino-3-((z)-1-propen-1-yl)-3 -cephem-4-carboxylic acid - useful in prodn. of broadband antibiotics
PT630380E (en) * 1992-02-05 2002-02-28 Biochemie Gmbh PROCESS FOR THE PURIFICATION OF A DERIVATIVE OF 3-CEFEM-4-CARBOXYLIC ACID
JPH07173168A (en) * 1993-07-14 1995-07-11 Sumitomo Chem Co Ltd Cephem compound, its production and utilization of the compound for production of cephem antibiotic substance
WO2004033464A1 (en) * 2002-10-08 2004-04-22 Ranbaxy Laboratories Limited Process for the preparation of (z)-isomer enriched 7-amino-3-propen-1-yl-3-cephem-4- carboxylic acid
US7544797B2 (en) 2003-10-30 2009-06-09 Cj Cheiljedang Corporation Processes for the preparation of cephem derivatives
WO2006048887A1 (en) * 2004-11-01 2006-05-11 Hetero Drugs Limited A novel process for preparation of cefprozil intermediate
CN103183686B (en) * 2011-12-30 2016-06-29 浙江新和成股份有限公司 The preparation method of 7 beta-amino-7 α-methoxyl group-3-cephem compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110534A (en) * 1970-01-23 1978-08-29 Glaxo Laboratories Limited Process for the preparation of 3-vinyl and substituted vinyl cephalosporins
US3769277A (en) * 1970-01-23 1973-10-30 Glaxo Lab Ltd Preparation of delta3-4 carboxy cephalosporins having a 3-vinyl or substituted 3-vinyl group
GB1342241A (en) * 1970-01-23 1974-01-03 Glaxo Lab Ltd Cephalosporin compounds
US4065620A (en) * 1971-06-14 1977-12-27 Eli Lilly And Company 3-(Substituted) vinyl cephalosporins
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins
AU566944B2 (en) * 1983-10-07 1987-11-05 Gist-Brocades N.V. Preparation of 3-cephem derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118595A1 (en) * 2004-06-04 2005-12-15 Otsuka Chemical Co., Ltd. Process for production of 3-alkenylcephem compounds

Also Published As

Publication number Publication date
YU65986A (en) 1987-12-31
CY1571A (en) 1991-12-20
SG90890G (en) 1991-01-18
DK182486A (en) 1986-10-23
FR2580652B1 (en) 1989-01-06
CA1273629A (en) 1990-09-04
NL8601011A (en) 1986-11-17
NO164659B (en) 1990-07-23
YU43697B (en) 1989-10-31
NL192205C (en) 1997-03-04
FI84268B (en) 1991-07-31
FI861634A (en) 1986-10-23
JPH0327554B2 (en) 1991-04-16
AT392072B (en) 1991-01-25
NZ215717A (en) 1989-06-28
IE861048L (en) 1986-10-22
DD244557A5 (en) 1987-04-08
ES554215A0 (en) 1987-10-16
AR242581A1 (en) 1993-04-30
OA08245A (en) 1987-10-30
ZM4286A1 (en) 1989-03-27
FI84268C (en) 1991-11-11
GR861065B (en) 1986-09-01
CH671399A5 (en) 1989-08-31
AU589170B2 (en) 1989-10-05
ES8800236A1 (en) 1987-10-16
NO861430L (en) 1986-10-23
FI861634A0 (en) 1986-04-17
SE8601825L (en) 1986-10-23
GB8609661D0 (en) 1986-05-29
DE3613365A1 (en) 1987-01-02
KR860008189A (en) 1986-11-12
DK182486D0 (en) 1986-04-21
DK163584C (en) 1992-08-10
CS287286A2 (en) 1989-11-14
HUT41033A (en) 1987-03-30
MY100694A (en) 1991-01-17
LU86402A1 (en) 1986-11-05
CN86102630A (en) 1987-02-04
IE59014B1 (en) 1993-12-15
HK106290A (en) 1990-12-28
ZW9086A1 (en) 1986-12-03
BE904646A (en) 1986-10-21
EG18001A (en) 1991-11-30
FR2580652A1 (en) 1986-10-24
ZA862985B (en) 1986-12-30
NL192205B (en) 1996-11-01
SE8601825D0 (en) 1986-04-21
NO164659C (en) 1990-10-31
PT82436A (en) 1986-05-01
CS270435B2 (en) 1990-06-13
IT8620162A0 (en) 1986-04-21
AU5616886A (en) 1986-11-06
CN1015714B (en) 1992-03-04
GB2173798A (en) 1986-10-22
SU1435155A3 (en) 1988-10-30
SE500217C2 (en) 1994-05-09
HU195223B (en) 1988-04-28
PT82436B (en) 1988-11-30
IT1228241B (en) 1991-06-05
DE3613365C2 (en) 1989-06-15
GB2173798B (en) 1988-11-30
DK163584B (en) 1992-03-16
ATA106786A (en) 1990-07-15

Similar Documents

Publication Publication Date Title
JPH0149271B2 (en)
US4266049A (en) Process for 3-iodomethyl cephalosporins
JPS61249989A (en) 7-amino-3-propenylcephalosporanic acid and ester
EP0043546B1 (en) 7-oxo-cephalosporins and 6-oxo-penicillins, their analogues and process for their preparation
JPH0560473B2 (en)
NO147916B (en) PROCEDURE FOR THE PREPARATION OF 3-METHYLENE-CEPHALOSPORINE COMPOUNDS.
US4699979A (en) 7-amino-3-propenylcephalosporanic acid and esters thereof
JPS6133833B2 (en)
JPH02790A (en) Production of 7-(2-(2-aminothiazol-4yl)-2-hydroxyiminoacetamide)-3-cephem compound
US4354022A (en) Process for preparing 3-methylenecepham compounds or a salt thereof
US4994454A (en) Cepham derivatives
US4145540A (en) 7β-Phosphoramido-7α-methoxycephalosporanic acid derivatives
US4094978A (en) 3-propenyl derivatives of cephalosporin, compositions and their use
DE2619243C2 (en) Process for the preparation of 3-acyloxymethyl-cephem compounds
JPS6129957B2 (en)
JPH0521912B2 (en)
US4115646A (en) Process for preparing 7-aminocephalosporanic acid derivatives
JPS60260584A (en) Cephalosporin derivative and its preparation
JP2867438B2 (en) Method for producing cephalosporin compounds
US3943126A (en) Process for acylating a 7-aminocephalosporin
KR790001503B1 (en) Process for preparing 3-cephalosporing esters
JPS5951555B2 (en) Method for producing cephalosporin compounds
KR810000635B1 (en) Process for preparing cephalosporin compounds
AT390617B (en) Process for the preparation of novel 7 beta-(D-2-amino(p- hydroxyphenyl)acetamido)-3-((Z)-1-propen-1-yl)-3-cephem-4- carboxylic acid derivatives
JPS58105993A (en) Novel beta-lactam derivative with isomeric structure

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term